Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NTLA compared with ARCT: revenue, margins and what each company keeps, and the suppliers and customers both name
NTLA
Intellia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NTLA
Intellia Therapeutics, Inc.
vs
ARCT
Arcturus Therapeutics Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
NTLA
Intellia Therapeutics, Inc.
Change
12.45
· pre 12.79
Mkt cap
$1.7B
Revenue
$8M
Q2 FY26
Revenue
$68M
FY25
ARCT
Arcturus Therapeutics Holdings Inc.
Change
11.01
· pre 11.01
· delayed
Pre-market
Sep 2 '83
Mkt cap
$313.5M
Revenue
$3M
Q2 FY26
Revenue
$82M
FY25
vs
Compare
Pre-market
Sep 2 '83
NTLA
Intellia Therapeutics, Inc.
vs
ARCT
Arcturus Therapeutics Holdings Inc.
12.45
pre 12.79
Price
11.01
pre 11.01
delayed
$1.7B
Mkt cap
$313.5M
Q2 FY26
$8M
Revenue
$3M
Q2 FY26
FY25
$68M
Revenue
$82M
FY25
Change
Change
NTLA
12.45
vs
ARCT
11.01
Pre-market
Sep 2 '83
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NTLA: latest quarter is a loss; flow not drawable. ARCT: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NTLA
4
REGN
Regeneron Pharmaceuticals
customer
CRBU
Caribou Biosciences
supplier
—
AvenCell Therapeutics
unlisted
customer
—
SparingVision SAS
unlisted
customer
Shared
0
No shared counterparties.
Only ARCT
3
—
Biomedical Advanced Research and Development Authority (BARDA)
unlisted
customer
—
CSL Seqirus
unlisted
customer
—
Meiji Seika Pharma
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NTLA, solid
ARCT, dashed